Lixte Biotechnology Holdings Stock Price on September 3, 2024
| LIXT Stock | USD 1.98 0.07 3.66% |
Below is the normalized historical share price chart for Lixte Biotechnology Holdings extending back to September 21, 2007. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Lixte Biotechnology stands at 1.98, as last reported on the 22nd of December, with the highest price reaching 2.14 and the lowest price hitting 1.85 during the day.
If you're considering investing in Lixte Stock, it is important to understand the factors that can impact its price. Lixte Biotechnology appears to be abnormally volatile, given 3 months investment horizon. Lixte Biotechnology has Sharpe Ratio of 0.0525, which conveys that the firm had a 0.0525% return per unit of risk over the last 3 months. By analyzing Lixte Biotechnology's technical indicators, you can evaluate if the expected return of 0.51% is justified by implied risk. Please exercise Lixte Biotechnology's Downside Deviation of 6.64, mean deviation of 5.03, and Risk Adjusted Performance of 0.0505 to check out if our risk estimates are consistent with your expectations.
At this time, Lixte Biotechnology's Total Stockholder Equity is comparatively stable compared to the past year. Other Stockholder Equity is likely to gain to about 51.4 M in 2024, whereas Common Stock is likely to drop 213.75 in 2024. . At this time, Lixte Biotechnology's Price Book Value Ratio is comparatively stable compared to the past year. Price Earnings To Growth Ratio is likely to gain to 0.01 in 2024, whereas Price To Operating Cash Flows Ratio is likely to drop (1.10) in 2024. Lixte Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 21st of September 2007 | 200 Day MA 2.2747 | 50 Day MA 1.863 | Beta (0.17) |
Lixte |
Sharpe Ratio = 0.0525
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | LIXT | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 9.77 actual daily | 86 86% of assets are less volatile |
Expected Return
| 0.51 actual daily | 10 90% of assets have higher returns |
Risk-Adjusted Return
| 0.05 actual daily | 4 96% of assets perform better |
Based on monthly moving average Lixte Biotechnology is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Lixte Biotechnology by adding it to a well-diversified portfolio.
Price Book 12.002 | Book Value 0.22 | Enterprise Value 6.3 M | Enterprise Value Ebitda (1.50) | Shares Float 2 M |
Related Headline
Quoin Pharmaceuticals Headline on 3rd of September 2024
Acquisition by Michael Myers of 800 shares of Quoin Pharmace... by Michael Myers
Filed transaction by Quoin Pharmaceuticals Ltd Director, Officer: Chief Executive Officer. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Lixte Biotechnology Valuation on September 3, 2024
It is possible to determine the worth of Lixte Biotechnology on a given historical date. On September 3, 2024 Lixte was worth 1.86 at the beginning of the trading date compared to the closed value of 1.83. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Lixte Biotechnology stock. Still, in general, we apply an absolute valuation method to find Lixte Biotechnology's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Lixte Biotechnology where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Lixte Biotechnology's related companies.
| Open | High | Low | Close | Volume | |
| 1.83 | 1.84 | 1.78 | 1.78 | 8,232 | |
09/03/2024 | 1.86 | 1.86 | 1.80 | 1.83 | 15,624 |
| 1.75 | 1.99 | 1.67 | 1.92 | 1,188,599 |
| Backtest Lixte Biotechnology | | | Lixte Biotechnology History | | | Lixte Biotechnology Valuation | Previous | Next |
Lixte Biotechnology Trading Date Momentum on September 3, 2024
| On September 04 2024 Lixte Biotechnology Holdings was traded for 1.92 at the closing time. The top price for the day was 1.99 and the lowest listed price was 1.67 . The trading volume for the day was 1.2 M. The trading history from September 4, 2024 was a factor to the next trading day price appreciation. The trading delta at closing time against the next closing price was 4.92% . The trading delta at closing time against the current closing price is 7.10% . |
Lixte Biotechnology Fundamentals Correlations and Trends
By evaluating Lixte Biotechnology's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Lixte Biotechnology's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Lixte financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Lixte Biotechnology Stock history
Lixte Biotechnology investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Lixte is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Lixte Biotechnology will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Lixte Biotechnology stock prices may prove useful in developing a viable investing in Lixte Biotechnology
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 1.9 M | 1.8 M | |
| Net Loss | -6.1 M | -5.8 M |
Lixte Biotechnology Quarterly Net Working Capital |
|
Lixte Biotechnology Stock Technical Analysis
Lixte Biotechnology technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Lixte Biotechnology Period Price Range
Low | December 22, 2024
| High |
0.00 | 0.00 |
Lixte Biotechnology Holdings cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Lixte Biotechnology December 22, 2024 Market Strength
Market strength indicators help investors to evaluate how Lixte Biotechnology stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Lixte Biotechnology shares will generate the highest return on investment. By undertsting and applying Lixte Biotechnology stock market strength indicators, traders can identify Lixte Biotechnology Holdings entry and exit signals to maximize returns
Lixte Biotechnology Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Lixte Biotechnology's price direction in advance. Along with the technical and fundamental analysis of Lixte Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Lixte to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0505 | |||
| Jensen Alpha | 0.4722 | |||
| Total Risk Alpha | 0.2242 | |||
| Sortino Ratio | 0.0713 | |||
| Treynor Ratio | 0.4681 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Lixte Stock Analysis
When running Lixte Biotechnology's price analysis, check to measure Lixte Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lixte Biotechnology is operating at the current time. Most of Lixte Biotechnology's value examination focuses on studying past and present price action to predict the probability of Lixte Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lixte Biotechnology's price. Additionally, you may evaluate how the addition of Lixte Biotechnology to your portfolios can decrease your overall portfolio volatility.